Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenonNaomi F. Rothfield, Fredrick M. Wigey, David Fiorentino et al.|Lund University Publications (Lund University)|2008Cited by 1